Latest Insider Transactions at Boston Scientific Corp (BSX)
This section provides a real-time view of insider transactions for Boston Scientific Corp (BSX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BOSTON SCIENTIFIC CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BOSTON SCIENTIFIC CORP's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 16
2023
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
568
-1.4%
|
$26,128
$46.48 P/Share
|
Feb 16
2023
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
1,838
+4.35%
|
-
|
Feb 16
2023
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,250
-0.45%
|
$57,500
$46.48 P/Share
|
Feb 16
2023
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,243
+1.49%
|
-
|
Feb 16
2023
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
910
-0.99%
|
$41,860
$46.48 P/Share
|
Feb 16
2023
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
2,050
+2.19%
|
-
|
Feb 16
2023
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,129
-4.19%
|
$51,934
$46.48 P/Share
|
Feb 16
2023
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
2,545
+8.62%
|
-
|
Feb 16
2023
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
1,806
-0.84%
|
$83,076
$46.48 P/Share
|
Feb 16
2023
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
3,960
+1.8%
|
-
|
Feb 16
2023
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,214
-0.39%
|
$331,844
$46.48 P/Share
|
Feb 16
2023
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,264
+0.88%
|
-
|
Feb 16
2023
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
1,409
-1.53%
|
$64,814
$46.79 P/Share
|
Feb 16
2023
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
909
-0.98%
|
$41,814
$46.48 P/Share
|
Feb 16
2023
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
2,970
+3.1%
|
-
|
Feb 15
2023
|
Daniel J. Brennan EVP and CFO |
SELL
Open market or private sale
|
Direct |
7,572
-2.67%
|
$355,884
$47.14 P/Share
|
Feb 15
2023
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,219
-0.43%
|
$57,293
$47.29 P/Share
|
Feb 15
2023
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,725
+2.03%
|
$35,175
$3.7 P/Share
|
Feb 15
2023
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
323
-0.83%
|
$15,181
$47.29 P/Share
|
Feb 15
2023
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
923
+2.32%
|
-
|
Feb 15
2023
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
819
-3.25%
|
$38,493
$47.29 P/Share
|
Feb 15
2023
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
1,846
+6.82%
|
-
|
Feb 15
2023
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
737
-0.82%
|
$34,639
$47.29 P/Share
|
Feb 15
2023
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
1,661
+1.81%
|
-
|
Feb 15
2023
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
2,488
-1.16%
|
$116,936
$47.29 P/Share
|
Feb 15
2023
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
4,615
+2.11%
|
-
|
Feb 15
2023
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,186
-0.45%
|
$384,742
$47.29 P/Share
|
Feb 15
2023
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,457
+1.0%
|
-
|
Feb 15
2023
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
622
-0.69%
|
$29,234
$47.29 P/Share
|
Feb 15
2023
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
2,031
+2.19%
|
-
|
Feb 15
2023
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
340
-1.02%
|
$15,980
$47.29 P/Share
|
Feb 15
2023
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
739
+2.17%
|
-
|
Feb 15
2023
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
548
-1.51%
|
$25,756
$47.29 P/Share
|
Feb 15
2023
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,200
+3.21%
|
-
|
Feb 15
2023
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Payment of exercise price or tax liability
|
Direct |
1,069
-1.71%
|
$50,243
$47.29 P/Share
|
Feb 15
2023
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
1,846
+2.87%
|
-
|
Feb 13
2023
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Bona fide gift
|
Direct |
11,000
-4.98%
|
-
|
Feb 10
2023
|
Wendy Carruthers EVP, Human Resources |
SELL
Bona fide gift
|
Direct |
2,195
-2.42%
|
-
|
Feb 09
2023
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Bona fide gift
|
Indirect |
630
+12.67%
|
-
|
Feb 09
2023
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Bona fide gift
|
Direct |
2,520
-1.13%
|
-
|
Feb 06
2023
|
John Bradley Sorenson EVP, Global Operations |
SELL
Bona fide gift
|
Direct |
4,779
-12.01%
|
-
|
Feb 03
2023
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Open market or private sale
|
Direct |
27,000
-53.58%
|
$1,296,000
$48.74 P/Share
|
Feb 03
2023
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
15,034
+13.35%
|
$240,544
$16.79 P/Share
|
Jan 06
2023
|
Charles J Dockendorff Director |
SELL
Bona fide gift
|
Indirect |
8,201
-100.0%
|
-
|
Jan 04
2023
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
6,751
-7.09%
|
$310,546
$46.38 P/Share
|
Jan 01
2023
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,042
-1.46%
|
$185,932
$46.27 P/Share
|
Jan 01
2023
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,134
+4.52%
|
-
|
Jan 01
2023
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
3,904
-9.94%
|
$179,584
$46.27 P/Share
|
Jan 01
2023
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
8,405
+17.63%
|
-
|
Jan 01
2023
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
3,100
-3.3%
|
$142,600
$46.27 P/Share
|